98 related articles for article (PubMed ID: 15795691)
1. Treatment and prophylaxis with sucralfate ameliorates hypoxia/reoxygenation-induced intestinal injury in pup rats.
Sencan AB; Sencan A; Aktas S; Habif S; Kabaroglu C; Parildar Z; Karaca I
Med Sci Monit; 2005 Apr; 11(4):BR126-30. PubMed ID: 15795691
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Y-27632 on hypoxia/reoxygenation-induced intestinal injury in newborn rats.
Balyemez G; Sivasli E; Ceylan H; Tutar E; Ekiz S; Tarakcioglu M; Demiryurek AT; Coskun MY
J Pediatr Surg; 2011 Aug; 46(8):1490-4. PubMed ID: 21843713
[TBL] [Abstract][Full Text] [Related]
3. Does sucralfate prevent apoptosis occurring in the ischemia/reperfusion-induced intestinal injury?
Sencan A; Yilmaz O; Ozer E; Günşar C; Genç K; Ulukuş C; Taneli C; Mir E
Eur J Pediatr Surg; 2003 Aug; 13(4):231-5. PubMed ID: 13680490
[TBL] [Abstract][Full Text] [Related]
4. Does maternal nicotine exposure during gestation increase the injury severity of small intestine in the newborn rats subjected to experimental necrotizing enterocolitis.
Ozkan KU; Ozokutan BH; Inanç F; Boran C; Kilinç M
J Pediatr Surg; 2005 Mar; 40(3):484-8. PubMed ID: 15793722
[TBL] [Abstract][Full Text] [Related]
5. Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats.
Biçakçi U; Tander B; Aritürk E; Aydin BK; Aydin O; Rizalar R; Eren Z; Bernay F
Pediatr Surg Int; 2005 Oct; 21(10):800-5. PubMed ID: 16205929
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline therapy attenuates intestinal injury in rat pups with hypoxic ischemic encephalopathy.
Kalay S; Islek A; Ozturk A; Kalay Z; Elpek O; Aldemir H; Akçakuş M; Oygur N
J Matern Fetal Neonatal Med; 2014 Sep; 27(14):1476-80. PubMed ID: 24195683
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C reduces intestinal injury in an experimental model of necrotizing enterocolitis.
Kumral A; Yesilirmak DC; Tugyan K; Baskin H; Tekman I; Duman N; Ozkan H
J Pediatr Surg; 2010 Mar; 45(3):483-9. PubMed ID: 20223309
[TBL] [Abstract][Full Text] [Related]
8. Effects of whole-body hypoxic preconditioning on hypoxia/reoxygenation-induced intestinal injury in newborn rats.
Ceylan H; Yüncü M; Gürel A; Armutçu F; Gergerlioğlu HS; Bağci C; Demiryürek AT
Eur J Pediatr Surg; 2005 Oct; 15(5):325-32. PubMed ID: 16254844
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats.
Cadir FO; Bicakci U; Tander B; Kilicoglu-Aydin B; Rizalar R; Ariturk E; Aydin O; Bernay F
Pediatr Surg Int; 2008 Jul; 24(7):809-13. PubMed ID: 18427813
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of recombinant human interleukin-4 administration on the hypoxia-reoxygenation-induced gastric and intestinal injury in rat pups.
Ozturk H; Ozturk H; Buyukbayram H
Fetal Pediatr Pathol; 2005; 24(6):347-58. PubMed ID: 16761563
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor attenuates apoptosis and mucosal damage in hypoxia/reoxygenation-induced intestinal injury.
Ozen S; Akisu M; Baka M; Yalaz M; Sozmen EY; Berdeli A; Kultursay N
Biol Neonate; 2005; 87(2):91-6. PubMed ID: 15528875
[TBL] [Abstract][Full Text] [Related]
12. [Effect of L-alanyl-L-glutamine on expression of insulin-like growth factor-1 in intestinal tissues of low-birth-weight newborn rats with hypoxia/reoxygenation-induced intestinal injury].
Xu F; Zhu CR; Zhan YL; Lu GJ; Su HB
Zhongguo Dang Dai Er Ke Za Zhi; 2015 May; 17(5):502-7. PubMed ID: 26014704
[TBL] [Abstract][Full Text] [Related]
13. Influence of stress ulcer prophylaxis on translocation of bacteria from the intestinal tract in rats.
Georgopoulos A; Feistauer SM; Makristathis A; Burgmann H; Laggner AN
Wien Klin Wochenschr; 1996; 108(11):321-5. PubMed ID: 8767984
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation.
Kumral A; Baskin H; Duman N; Yilmaz O; Tatli M; Ozer E; Gökmen N; Genc S; Ozkan H
Biol Neonate; 2003; 84(4):325-9. PubMed ID: 14593244
[TBL] [Abstract][Full Text] [Related]
15. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
May B
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
[TBL] [Abstract][Full Text] [Related]
16. Sucralfate: prophylaxis of mucosal damage during cancer therapy.
Henriksson R; Franzén L; Edbom C; Littbrand B
Scand J Gastroenterol Suppl; 1995; 210():45-7. PubMed ID: 8578206
[TBL] [Abstract][Full Text] [Related]
17. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
18. A model of hypoxia-induced necrotizing enterocolitis: the role of distension.
Kazez A; Küçükaydin N; Küçükaydin M; Kontaş O; Okur H; Doğan P
J Pediatr Surg; 1997 Oct; 32(10):1466-9. PubMed ID: 9349771
[TBL] [Abstract][Full Text] [Related]
19. Sucralfate modulates uPAR and EGFR expression in an experimental rat model of cervicitis.
Mannari C; Santi S; Migliori M; Filippi C; Origlia N; Sansò M; Boldrini E; Giovannini L
Int J Immunopathol Pharmacol; 2008; 21(3):651-8. PubMed ID: 18831933
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of peptic ulcer with sucralfate].
Brailski Kh; Mendizova A; Matov V; Dimitrov B
Klin Med (Mosk); 1991 Aug; 69(8):78-80. PubMed ID: 1791718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
